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Background: Several years ago, repetitive transcranial magnetic stimulation (rTMS) of the auditory cortex has been
introduced as a treatment approach for chronic tinnitus. Even if this treatment is beneficial for a subgroup of
patients, the overall effects are limited. This limitation may be due to the fact that the auditory cortex is only one of
several brain areas involved in tinnitus. Whereas auditory areas are considered to code for tinnitus loudness,
conscious perception of and attention allocation to tinnitus is supposed to be reflected by network activity
involving frontal and parietal cortical areas. The aim of the present study is to influence this frontoparietal network
more efficiently by perturbing the most important nodes with rTMS.
Methods/design: This is a randomized, double-blind, parallel-group study. Patients receive rTMS treatment on 10
consecutive working days using either the multisite rTMS protocol (left dorsolateral prefrontal, 1,000 stimuli, 20 Hz;
left temporoparietal, 1,000 stimuli, 1 Hz; right temporoparietal stimulation, 1,000 stimuli, 1 Hz) or a single-site
protocol (unilateral stimulation of the temporoparietal cortex, 3,000 stimuli, 1 Hz). Individuals aged 18 to 70 years
with chronic tinnitus ≥6-month duration and a Tinnitus Handicap Inventory score ≥38 are recruited for the study. A
total of 50 patients are needed to detect a clinical relevant change of tinnitus severity (α = 0.05; 1 – β = 0.80).
Primary outcome measures are the change in the Tinnitus Questionnaire score from baseline to the end of
treatment as well as the number of treatment responders as defined by a reduction in the Tinnitus Questionnaire
score of ≥5 points. Furthermore, changes in brain structure and activity are assessed using (functional) magnetic
resonance imaging and electroencephalography in the resting state. Those measurements are also performed in 25
healthy control subjects.
Discussion: This study is designed to reveal whether network stimulation is superior to single-site stimulation in
the treatment of chronic tinnitus. Furthermore, the comparison between tinnitus patients and healthy controls and
the longitudinal effects of both rTMS treatment protocols on brain structure and function allow inferences to be
made about the neural correlates of tinnitus.
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Subjective tinnitus is the auditory sensation of sound or
noise in the absence of an acoustic stimulus. About 10
to 15% of adults in western societies report to suffer
from tinnitus [1]. Tinnitus may have many etiologies
and can involve severe psychological distress [2]. The
neurobiological mechanisms underlying tinnitus are still
incompletely understood, and causally oriented treat-
ment options are scarce. Neuroimaging and electroen-
cephalography (EEG)/magnetoencephalography (MEG)
studies have revealed increased neural activity in central
auditory pathways [3-8] and have demonstrated alter-
ations in the frequency spectrum power during resting
state activity in tinnitus patients [9]. Based on the
hypothesis that repetitive transcranial magnetic stimula-
tion (rTMS) can reduce tinnitus by interfering noninva-
sively with abnormal activity in the auditory cortex, this
method has been investigated for the treatment of
tinnitus [10-12]. rTMS treatment in tinnitus patients is
so far still of questionable clinical benefit [13], and
therefore is not yet ready for application in the clinical
routine. Taking into account the lack of other causally
oriented treatment options for tinnitus, rTMS treat-
ment is nevertheless considered a promising technique,
and miscellaneous optimization strategies have been
proposed [14].
In the current study an innovative optimization ap-
proach is used that is motivated by the recent finding
in tinnitus patients that alterations of brain activity
are not restricted to the auditory cortex but involve a
network of both auditory and nonauditory brain re-
gions [15-17]. Important nodes of this tinnitus
network include the left and right auditory cortex, the
anterior and posterior cingulate cortex, left frontal
and parietal cortical areas. These areas and their func-
tional interconnection are thought to reflect the
conscious perception of tinnitus and the attention
allocation to the percept [17-20]. Aiming to increase
the therapeutic efficacy of rTMS, we propose a new
multisite stimulation protocol interfering with this
tinnitus network at several nodes. The multisite
stimulation protocol consists of high-frequency left
dorsolateral prefrontal stimulation followed by left
and right temporoparietal low-frequency rTMS and
has already been tested in a pilot study [21]. This pilot
study showed promising effects. The new protocol
should now be examined in a double-blind random-
ized controlled trial (blinding of the patient and the
clinicians involved in ratings and data analysis) to
determine whether it is able to disrupt the altered
activity within the tinnitus network. As tinnitus has
been shown to be associated with altered connectivity
patterns [15-17], EEG and functional magnetic reson-
ance imaging (MRI) measurements will be used toreplicate those results and to examine the effect of
rTMS on these alterations.
Objectives
Based on the findings in the pilot study, we hypothesize
that the reduction of the Tinnitus Questionnaire (TQ)
score as well as the number of treatment responders after
10 days of rTMS treatment and after follow-up periods of
3 and 6 months are higher when patients are treated using
the new multisite stimulation protocol in comparison with
single-site stimulation of the temporoparietal cortex.
Treatment response is defined as an improvement of ≥5
points in the TQ score [22]. Further aims of the study
are as follows: to compare multisite stimulation with
single-site stimulation with respect to a change of tin-
nitus severity as measured by the TQ, the Tinnitus
Handicap Inventory (THI) and numeric rating scales
assessing the loudness and annoyance of the tinnitus
percept (baseline vs. end of treatment and all follow-up
visits); to compare single-site stimulation with multisite
stimulation with respect to a change in secondary out-
comes such as quality of life, hyperacusis and depressive
symptoms (baseline vs. end of treatment and all follow-
up visits); to replicate and expand findings concerning
the neural correlates of tinnitus using resting state EEG,
MRI and resting-state functional MRI; to examine
whether successful treatment with rTMS is correlated
with changes in brain structure and activity; to examine
whether treatment with multisite rTMS induces different
brain changes than treatment with single-site rTMS (we
assume that network alterations associated with tinnitus
can be influenced more effectively using multisite stimula-
tion as compared with single-site rTMS); and to determine
whether brain structure and activity as measured by EEG
and functional MRI at baseline are predictive for treat-
ment response.
Methods/design
Design of the trial
This trial is a two-arm, randomized, double-blind parallel-
group study of 2 weeks of rTMS treatment plus 12-week
and 24-week follow-up visits in patients with moderate to
severe chronic subjective tinnitus. The trial is performed
at the multidisciplinary tinnitus clinic at the University
of Regensburg. Fifty patients are randomly assigned to a
2-week rTMS treatment either with a single-site rTMS
protocol or with the new multisite protocol.
Study population
Patients
Fifty patients are included in the study. Patients are eli-
gible for study participation if they meet the following
inclusion criteria: diagnosis of chronic subjective tin-
nitus; duration of tinnitus ≥6 months; score ≥38 on the
Lehner et al. Trials 2013, 14:269 Page 3 of 6
http://www.trialsjournal.com/content/14/1/269THI at screening; age between 18 and 70 years; and
written informed consent.
The study exclusion criteria were: objective tinnitus;
treatable cause of the tinnitus; prior treatment with
transcranial magnetic stimulation; clinically relevant un-
stable psychiatric, internal or neurological comorbidity;
history or evidence of significant brain malformation,
neoplasm, head injury or cerebral vascular events; metal
objects in and around the body that cannot be removed,
cardiac pacemakers, other electronic implants; history of
seizures or epileptic activity; pregnancy; alcohol or drug
abuse; and intake of benzodiazepines ≥1 mg lorazepam/
day (or equivalent doses of other benzodiazepines).
Control subjects
To potentially replicate and expand findings concerning
the neural correlates of tinnitus, 25 control subjects with-
out tinnitus but matched for age, gender and hearing
function are examined once using EEG, MRI, functional
MRI and all questionnaires (except for the tinnitus-
specific ones). Inclusion criteria for the control subjects
are age between 18 and 70 years and written informed
consent. Exclusion criteria are identical to the exclusion
criteria for patients except for the first three criteria.
Procedures
Patients are recruited during routine clinical tinnitus
consultations, via print-media announcement and via
the homepage of the multidisciplinary tinnitus clinic at
the University of Regensburg. At screening, all patients
are asked to fill in the Tinnitus Sample Case History
Questionnaire [23], and inclusion/exclusion criteria aretreatment:
10 working days
(2 x monday - friday)
week 1 week 2






















Figure 1 Visit schedule. EEG, electroencephalography; (f)MRI, (functional)
stimulation.checked. After screening and giving written informed
consent, patients are examined in a baseline visit that
involves structural MRI, resting state functional MRI and
resting state EEG measurements (see Figure 1). Those
measurements are repeated after completion of rTMS
treatment. After a 3-month follow-up period, an add-
itional resting state EEG measurement is done. Further-
more, questionnaires have to be filled out at different time
points including follow-up visits after 3 and 6 months (see
Figure 1).
(Functional) MRI/electroencephalography
The MRI scans are performed on a Siemens Allegra 3-
Tesla head scanner (Siemens AG, Erlangen, Germany)
with a single channel headcoil. First, a high-resolution T1
weighted image (160 sagittal slices covering the whole
brain, 1 × 1 × 1 mm3 voxel size, field of view = 256 ×
256 mm2) is acquired from each subject using the ADNI
sequence (repetition time = 2250 ms, echo time = 2.6 ms,
flip angle = 9°). Then 6 minutes of resting state functional
MRI are performed using a T2* weighted gradient echo-
planar imaging sequence (repetition time = 2 seconds,
echo time = 30 ms, 34 slices, field of view = 192 ×
192 mm2, flip angle = 90°, 3 × 3 × 3 mm3 voxel size). The
EEG equipment consists of the BrainAmp DC amplifier
(Brain Products, Herrsching, Germany) and EEG record-
ing caps with the possibility to place up to 64 electrodes
(10–20 System; EasyCap, Gilching, Germany). The EEG
is recorded from 62 electrodes with impedances below
10 kΩ and a sampling rate of 500 Hz. A resting state
EEG measurement is carried out for 7 minutes with eyes
closed.follow-up 1: 























magnetic resonance imaging; rTMS, repetitive transcranial magnetic
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To assess tinnitus severity, tinnitus patients have to fill
in different tinnitus questionnaires at several time points
(see Figure 1): the THI, the German version of the TQ
[22,24] and numeric rating scales for tinnitus loudness
and annoyance. In addition, depressive symptoms, qual-
ity of life and hyperacusis are assessed using the Major
Depression Inventory, the World Health Organization
Quality of Life assessment and a German hyperacusis
questionnaire [25].
Treatments
On the first treatment day, patients are randomized to
one of the following two parallel groups.
The multisite group is treated with the new multisite
rTMS protocol consisting of high-frequency stimulation
of the left dorsolateral prefrontal cortex (20 Hz, 1000
stimuli/day, which are applied in 20 trains with an
intertrain interval of 25 seconds) followed by 1000 stim-
uli at 1 Hz over the left temporoparietal cortex and 1000
stimuli at 1 Hz over the right temporoparietal cortex.
The stimulation parameters have been chosen according
to a pilot study [21] with a slight modification with
respect to the number of stimuli. A detailed explanation
for the choice of protocol can be found in Lehner and
colleagues [21].
The single-site group is treated with a single-site rTMS
protocol consisting of 3000 stimuli/day that are applied at
1 Hz over the temporoparietal cortex contralateral to the
tinnitus percept [26]. Based on former studies, the left
hemisphere is treated in case of bilateral tinnitus (for ex-
ample [27]). Since the goal of this study is to demonstrate
superiority of the multisite stimulation over the current
standard approach (stimulation of the temporoparietal
cortex), an active stimulation protocol was chosen for
comparison instead of placebo stimulation.
All patients receive 10 treatment sessions on 10 con-
secutive working days. The total number of stimuli per
session is identical for both treatment groups (3000 stim-
uli per session). rTMS is performed with an intensity of
110% of the resting motor threshold but never higher than
60% of the maximal stimulator output. The resting motor
threshold is determined at the beginning of the first treat-
ment session and is defined as the minimal intensity at
which at least five of 10 motor evoked potentials are
50 μV in amplitude in the right abductor digiti minimi.
rTMS treatment is performed with a Medtronic MagPro
Option stimulator (Medtronic, Minneapolis, MN, USA)
connected to a 70 mm figure-of-eight coil. The coil is held
tangential to the scalp with the handle pointing up-
wards. The temporoparietal cortices are localized using
the 10–20 System by placing the coil between the tem-
poral (T3/T4) and the parietal (P3/P4) EEG electrode sites
[28,29]. The dorsolateral prefrontal cortex is targeted bycentering the coil 6 cm anterior from the part of the
motor cortex that had been used for defining the resting
motor threshold.
rTMS treatment is applied by nonblinded study staff not
involved in any other study-specific procedures. Patient
management and assessment, functional MRI and EEG
measurements and the statistical analyses are done by
psychologists and physicians who are blinded with
respect to treatment conditions.
Outcome measures
The primary outcome measures are the change in the
TQ score from baseline to end of treatment (interaction
effect time × group) as well as the number of treatment
responders as defined by a reduction in the tinnitus
questionnaire score of ≥5 points at the end of treatment.
Secondary outcome measures are changes in all scales
and questionnaires (TQ, THI, numeric rating scales,
Major Depression Inventory, World Health Organization
Quality of Life assessment, hyperacusis questionnaire)
between baseline and end of treatment as well as between
baseline and all follow-up periods. Furthermore, the num-
ber of treatment responders at all follow-up time points is
examined.
Blinding
Patients, clinical raters and data analysts are blind to treat-
ment conditions. As the treatment group is easily realized
by the number of brain areas stimulated (one in the con-
trol group vs. three in the treatment group), patients are
informed that two active stimulation procedures are com-
pared without specifying the exact difference between the
two protocols.
Randomization
An online generator was used to prepare a balanced
randomization list before the trial started. The whole
sample was used as one block. Only the nonblinded clin-
ical staff are granted access to this list and perform
randomization prior to the first treatment session.
Determination of sample size
The study is designed to find an interaction effect be-
tween group (single-site vs. multisite) and time (baseline,
end of treatment). Based on our pilot data [21] a small
effect size of f = 0.1 for this interaction effect is assumed.
Although small, such an effect is still an important step
in tinnitus management. If the study sample size is
determined to provide sufficient power (0.8) for detec-
tion of such an effect in a repeated-measures analysis of
variance (with α = 0.05), a total of 42 tinnitus patients
have to be examined. Due to the complex and time-
consuming study design, a higher patient dropout rate
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group) are therefore planned to be included in the study.
Statistical analysis
Missing data entries are handled with the last observation
carried forward method. For the comparison of treatment
responders in both groups, a chi-square statistic is calcu-
lated. For all secondary outcomes, an analysis of variance
is used with the between-subjects factor group (multisite
rTMS vs. single-site rTMS) and the repeated-measures
factor time (baseline vs. end of treatment vs. all follow-up
time points). EEG and (functional) MRI data are analyzed
with MatLab-based analytic software (MathWorks,
Natick, MA, USA; EEGLAB; FieldTrip; SPM). For both
EEG and functional MRI data, different exploratory
analyses focusing predominantly on connectivity mea-
sures will be done. As it is hypothesized to find altered
connectivity patterns in tinnitus patients, imaging/EEG
data of both patient groups are compared with data for
the control group (baseline measurements of the tinnitus
groups vs. single measurement of the controls). Further-
more, longitudinal analyses will be performed to test for a
change of the connectivity patterns from before to after
rTMS treatment (contrast: pre rTMS vs. post rTMS).
Correlations of imaging data and questionnaire scores are
used to identify potential predictors for rTMS outcome.
As the present protocol has a clinical focus, we do not go
into detail concerning the EEG and functional MRI
analyses at this point.
Ethical aspects
The study protocol has been approved by the ethics com-
mittee of the University of Regensburg (10-101-0169). The
study is performed in agreement with the principles of the
Declaration of Helsinki. All patients are informed about
the purpose and the risks of the study and about their
right to withdraw their consent at any time. Patients are
only included in the study if written informed consent is
given.
Discussion
rTMS has been used as a treatment approach for chronic
tinnitus for several years. Results from clinical trials are
heterogeneous; in summary, the effect size of rTMS treat-
ment over the auditory cortex has been shown to be rather
small. The idea of interfering with altered brain activity via
noninvasive brain stimulation is plausible, however, and
the efficacy of a specific treatment protocol depends on
the quality of the neurobiological model underlying that
protocol. During the last few years, knowledge about the
neurobiological mechanisms of tinnitus has advanced [20].
Neuroscientists have moved away from a model restricted
to the auditory system towards the concept of a more
widespread tinnitus network. This new model of tinnituscan and should now be used to improve rTMS treatment.
The attempt to adapt rTMS treatment to the network
model brings several methodological difficulties about
which had to be dealt with in the design of this trial. The
tinnitus network as described by Schlee and colleagues in-
volves several brain regions, all of which can be stimulated
with different frequencies in a different order and with a
varying number of stimuli [17]. One of the many possible
treatment protocols therefore had to be chosen [21]. The
attempt of this study is not to find the best of all possible
protocols but to determine whether a multisite stimulation
protocol based on recent studies on the tinnitus network
is superior to the standard protocol used in tinnitus treat-
ment. This reason is also why the standard protocol was
used as control treatment instead of a placebo control.
Having these constraints in mind, the study is capable of
providing useful information about a new way to use
rTMS in tinnitus patients. By using EEG and (functional)
MRI we are able to determine whether both treatment
protocols induce different changes in brain structure and
function and whether multisite stimulation serves the pur-
pose of interfering with the tinnitus network. Further-
more, the comparison between clinical changes and
changes in neuroimaging findings over time provides a
unique opportunity for further specifying the exact role of
the neuronal network changes underlying tinnitus percep-
tion and distress.
Trial status
The trial started recruitment in July 2012 and will pre-
sumably complete follow-up assessments in 2014.
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